Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia. Luskin MR, Keating JH, Frost BF, Jaeckle SL, et al. Blood 2026 Sep 25:blood.2026035238. doi: 10.1182/blood.2026035238.

Read + Share

Amedeo Smart

Independent Medical Education

Luskin MR, Keating JH, Frost BF, Jaeckle SL, et al. Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia. Blood 2026 Sep 25:blood.2026035238. doi: 10.1182/blood.2026035238.
PMID: 42789493